Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

HOW TO MEASURE COMORBIDITY IN PATIENTS SELECTED FOR RADICAL PROSTATECTOMY?

0
Posted

HOW TO MEASURE COMORBIDITY IN PATIENTS SELECTED FOR RADICAL PROSTATECTOMY?

0

Froehner M., Koch R., Litz R., Oehlschlaeger S., Hakenberg O., Wirth M. Technical University of Dresden, Department of Urology, Dresden, Germany INTRODUCTION & OBJECTIVES: To compare different comorbidity classifications as predictors of survival after radical prostatectomy (RPE). MATERIAL & METHODS: 444 consecutive RPE patients (mean follow-up 5.9 years) were stratified according to age, Charlson score, Charlson score restricted to the four most important single conditions, American Society of Anaesthesiologists Physical Status classification (ASA), New York Heart Association classification of cardiac insufficiency, classification of angina pectoris of the Canadian Cardiovascular Society and a combination of both cardiac risk scores. Comorbid and overall mortality were the study endpoints. Mantel-Haenszel hazard ratios and p values (log rank test, p<0.05 was considered significant) were used as measures for comparison. RESULTS: When three strata (low, intermediate, high risk) were use

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.